The US approves Pfizer booster shots for the 5-11 age group against COVID-19
The United States has approved Pfizer's booster shots for the 5-11 age group against COVID-19. The decision comes at a time when COVID-19 cases are increasing in the US.
The United States has approved Pfizer's booster shots for the 5-11 age group against COVID-19. The decision comes at a time when COVID-19 cases are increasing in the US.